| Marshall Edward Noel, MD | |
|
6167 N Fresno St Ste 102, Fresno, CA 93710-8610 | |
| (559) 322-2255 | |
| (559) 322-4636 |
| Full Name | Marshall Edward Noel |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 46 Years |
| Location | 6167 N Fresno St Ste 102, Fresno, California |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184718280 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | C400030 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Agnes Medical Center | Fresno, CA | Hospital |
| Fresno Surgical Hospital | Fresno, CA | Hospital |
| Clovis Community Medical Center | Clovis, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Canterbury Womens Health Care Medical Group Inc | 3173566163 | 2 |
News Archive
Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which uses previously unknown features to protect their DNA.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the treatment and prevention of infectious diseases, announced today that the Department of Defense through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program, a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.
A new study has found that although children treated for soft tissue sarcomas are surviving longer than they did in the past, they have an increased risk for second cancers, especially when initial treatment combined radiation and chemotherapy. This is according to analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.
Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its Board of Directors has authorized the repurchase of up to $2 million of its outstanding common stock. This decision reflects the Company's continued commitment to increasing value for its stockholders and its confidence that it will achieve its goals.
› Verified 1 days ago
| Entity Name | Canterbury Womens Health Care Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891889994 PECOS PAC ID: 3173566163 Enrollment ID: O20050610000194 |
News Archive
Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which uses previously unknown features to protect their DNA.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the treatment and prevention of infectious diseases, announced today that the Department of Defense through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program, a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.
A new study has found that although children treated for soft tissue sarcomas are surviving longer than they did in the past, they have an increased risk for second cancers, especially when initial treatment combined radiation and chemotherapy. This is according to analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.
Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its Board of Directors has authorized the repurchase of up to $2 million of its outstanding common stock. This decision reflects the Company's continued commitment to increasing value for its stockholders and its confidence that it will achieve its goals.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marshall Edward Noel, MD 6167 N Fresno St Ste 102, Fresno, CA 93710-8610 Ph: (559) 322-2255 | Marshall Edward Noel, MD 6167 N Fresno St Ste 102, Fresno, CA 93710-8610 Ph: (559) 322-2255 |
News Archive
Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which uses previously unknown features to protect their DNA.
Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the treatment and prevention of infectious diseases, announced today that the Department of Defense through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program, a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.
A new study has found that although children treated for soft tissue sarcomas are surviving longer than they did in the past, they have an increased risk for second cancers, especially when initial treatment combined radiation and chemotherapy. This is according to analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.
Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its Board of Directors has authorized the repurchase of up to $2 million of its outstanding common stock. This decision reflects the Company's continued commitment to increasing value for its stockholders and its confidence that it will achieve its goals.
› Verified 1 days ago
Dr. Roydon Glen Fredrick Steinke, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6327 N Fresno St, Suite 101, Fresno, CA 93710 Phone: 559-435-5278 Fax: 559-435-7195 | |
Ms. Patricia Kay Felton, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7050 N Recreation Ave, #102, Fresno, CA 93720 Phone: 559-322-2900 Fax: 559-322-2901 | |
Dr. Robert Eugene Curry, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1374 E Alluvial Ave, Fresno, CA 93720 Phone: 559-981-2600 Fax: 559-981-2610 | |
Pamela Louise Emeney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2210 E Illinois Ave Ste 408, Fresno, CA 93701 Phone: 559-443-2694 Fax: 559-443-2696 | |
Mrs. Kim I Morris, N.P. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2210 E Illinois Ave Ste 505, Fresno, CA 93701 Phone: 559-266-8989 Fax: 559-266-8994 | |
Mr. Paul Madsen, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 290 N Wayte Ln, Fresno, CA 93701 Phone: 559-459-5755 Fax: 559-459-4453 | |
Elaine Winifred Morris, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1752 W Calimyrna Ave Apt B, Fresno, CA 93711 Phone: 559-451-0721 |